JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M112134200 on June 7, 2002

J. Biol. Chem., Vol. 277, Issue 33, 29719-29729, August 16, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/33/29719    most recent
M112134200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinez, E. D.
Right arrow Articles by Danielsen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinez, E. D.
Right arrow Articles by Danielsen, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Loss of Androgen Receptor Transcriptional Activity at the G1/S Transition*

Elisabeth D. Martinez and Mark DanielsenDagger

From the Department of Biochemistry and Molecular Biology, Georgetown University School of Medicine, Washington, D. C. 20007

Androgens are essential for the differentiation, growth, and maintenance of male-specific organs. The effects of androgens in cells are mediated by the androgen receptor (AR), a member of the nuclear receptor superfamily of transcription factors. Recently, transient transfection studies have shown that overexpression of cell cycle regulatory proteins affects the transcriptional activity of the AR. In this report, we characterize the transcriptional activity of endogenous AR through the cell cycle. We demonstrate that in G0, AR enhances transcription from an integrated steroid-responsive mouse mammary tumor virus promoter and also from an integrated androgen-specific probasin promoter. This activity is strongly reduced or abolished at the G1/S boundary. In S phase, the receptor regains activity, indicating that there is a transient regulatory event that inactivates the AR at the G1/S transition. This regulation is specific for the AR, since the related glucocorticoid receptor is transcriptionally active at the G1/S boundary. Not all of the effects of androgens are blocked, however, since androgens retain the ability to increase AR protein levels. The transcriptional inactivity of the AR at the G1/S junction coincides with a decrease in AR protein level, although activity can be partly rescued without an increase in receptor. Inhibition of histone deacetylases brings about this partial restoration of AR activity at the G1/S boundary, demonstrating the involvement of acetylation pathways in the cell cycle regulation of AR transcriptional activity. Finally, a model is proposed that explains the inactivity of the AR at the G1/S transition by integrating receptor levels, the action of cell cycle regulators, and the contribution of histone acetyltransferase-containing coactivators.


* This work was supported by Department of Defense predoctoral fellowship DAMD17-99-1-9199 (to E. M.) and by American Heart Association (Mid-Atlantic) Grant 9951256U (to M. D.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Georgetown University School of Medicine, Basic Science Bldg. Rm. 355, 3900 Reservoir Rd., NW, Washington, D. C. 20007. Tel.: 202-687-4169; Fax: 202-687-7186; E-mail: dan@bc.georgetown.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
C. J Burd, L. M Morey, and K. E Knudsen
Androgen receptor corepressors and prostate cancer
Endocr. Relat. Cancer, December 1, 2006; 13(4): 979 - 994.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Burd, C. E. Petre, L. M. Morey, Y. Wang, M. P. Revelo, C. A. Haiman, S. Lu, C. M. Fenoglio-Preiser, J. Li, E. S. Knudsen, et al.
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation
PNAS, February 14, 2006; 103(7): 2190 - 2195.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. J. Martin, V. Lardeux, and P. Lefebvre
The proliferating cell nuclear antigen regulates retinoic acid receptor transcriptional activity through direct protein-protein interaction
Nucleic Acids Res., July 29, 2005; 33(13): 4311 - 4321.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Narayanan, D. P. Edwards, and N. L. Weigel
Human Progesterone Receptor Displays Cell Cycle-Dependent Changes in Transcriptional Activity
Mol. Cell. Biol., April 15, 2005; 25(8): 2885 - 2898.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. J. Burd, C. E. Petre, H. Moghadam, E. M. Wilson, and K. E. Knudsen
Cyclin D1 Binding to the Androgen Receptor (AR) NH2-Terminal Domain Inhibits Activation Function 2 Association and Reveals Dual Roles for AR Corepression
Mol. Endocrinol., March 1, 2005; 19(3): 607 - 620.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Narayanan, A. A. Adigun, D. P. Edwards, and N. L. Weigel
Cyclin-Dependent Kinase Activity Is Required for Progesterone Receptor Function: Novel Role for Cyclin A/Cdk2 as a Progesterone Receptor Coactivator
Mol. Cell. Biol., January 1, 2005; 25(1): 264 - 277.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Yang, C.-M. Chen, P. Yan, T. H-M. Huang, H. Shi, M. Burger, I. Nimmrich, S. Maier, K. Berlin, and C. W. Caldwell
The Androgen Receptor Gene is Preferentially Hypermethylated in Follicular Non-Hodgkin's Lymphomas
Clin. Cancer Res., September 15, 2003; 9(11): 4034 - 4042.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. E. Petre-Draviam, S. L. Cook, C. J. Burd, T. W. Marshall, Y. B. Wetherill, and K. E. Knudsen
Specificity of Cyclin D1 for Androgen Receptor Regulation
Cancer Res., August 15, 2003; 63(16): 4903 - 4913.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
O. M. Tirado, E. D. Martinez, O. C. Rodriguez, M. Danielsen, D. M. Selva, J. Reventos, F. Munell, and C. A. Suarez-Quian
Methoxyacetic Acid Disregulation of Androgen Receptor and Androgen-Binding Protein Expression in Adult Rat Testis
Biol Reprod, April 1, 2003; 68(4): 1437 - 1446.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.